Serviço Integrado de Técnicas Endovasculares (SITE), Rua Siqueira Campos, 59, 203, Rio de Janeiro, RJ, Brazil.
Ann Cardiothorac Surg. 2012 Sep;1(3):304-10. doi: 10.3978/j.issn.2225-319X.2012.08.04.
In 2006, we began our experience with a novel technology for fully endovascular thoracoabdominal aneurysm repair, based on a custom-made, branched stent graft design. After 48 cases, we have learned and achieved substantial progress both in technical and in clinical skills. This paper describes the partial results of this ongoing experience.
Patients in this series were selected for the presence of thoracoabdominal aortic aneurysms, with or without dissection, which was present in one patient. The observation of extensive anatomical variations in several patients prompted changes in many of the basic stent graft configurations, which are also described.
Between August 2006 and June 2012, 48 patients were treated consecutively with custom-made branch stent grafts. The five patients with the longest follow-up available so far are at 71, 65, 60, 54 and 51 months post-procedure. The operative mortality rate, defined as death during or within a month of surgical hospitalization, was 21% (10 patients); each case is described herein. During postoperative follow up, nine patients died from causes not directly related to aneurysmal disease, at 3, 18, 20, 22, 24, 24, 37, 44 and 46 months. The main causes of death were myocardial infarction (four cases), cancer (two cases), gastrointestinal hemorrhage (one case), ischemic stroke (one case), and sepsis (one case). Permanent paraplegia occurred in one patient.
It is still too soon to compare the results of endovascular repair of thoracoabdominal aneurysms with those of open surgical series. Despite the active and rapid progress currently observed for the endovascular method, it is still far from reaching its state-of-the-art plateau or becoming a gold standard. Further technological and technical advances in endovascular stent grafting seem to have a clear potential to provide very satisfactory operative outcomes for thoracoabdominal aortic aneurysms.
2006 年,我们开始使用一种新型的全腔内胸主动脉瘤修复技术,该技术基于定制的分支支架移植物设计。在完成 48 例手术后,我们在技术和临床技能方面都取得了实质性的进步。本文介绍了这一持续进行中的经验的部分结果。
本系列中的患者均被选择患有胸主动脉瘤,伴有或不伴有夹层,其中 1 例患者有夹层。在几名患者中观察到广泛的解剖学变异后,我们对许多基本的支架移植物构型进行了更改,这些更改也进行了描述。
2006 年 8 月至 2012 年 6 月,连续对 48 例患者使用定制的分支支架移植物进行了治疗。目前可获得的随访时间最长的 5 例患者分别在手术后 71、65、60、54 和 51 个月时进行了随访。手术死亡率定义为术中或术后 1 个月内死亡,为 21%(10 例);本文中描述了每个病例的情况。在术后随访期间,9 例患者因与动脉瘤疾病无关的原因死亡,分别在术后 3、18、20、22、24、24、37、44 和 46 个月时死亡。死亡的主要原因包括心肌梗死(4 例)、癌症(2 例)、胃肠道出血(1 例)、缺血性中风(1 例)和败血症(1 例)。1 例患者发生永久性截瘫。
现在比较胸主动脉瘤的腔内修复结果与开放手术系列结果还为时过早。尽管目前观察到腔内方法的积极和快速进展,但它仍然远未达到其最先进的水平或成为金标准。腔内支架移植物的进一步技术和技术进步似乎为胸主动脉瘤提供非常满意的手术结果提供了明确的潜力。